Skip to main content
SpringerLink
Log in

Hepatocanalicular Cholestasis after 24 Years of Azathioprine Administration for Myasthenia Gravis

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Fig. 2

References

  1. Romagnuolo J, Sadowski DC, Lalor E, et al. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Transplantation 1993 Dec; 56(6): 1415–8

    Article  Google Scholar 

  2. DeLeve LD, Wang X, Kuhlenkamp JF, et al. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23: 589–99

    Article  PubMed  CAS  Google Scholar 

  3. Gane E, Portmann B, Saxena R, et al. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994 Jul; 20 (1 Pt 1): 88–94

    Article  PubMed  CAS  Google Scholar 

  4. Mion F, Cloix P, Boillot O, et al. Veno-occlusive disease after liver transplantation. Association of acute cellular rejection and toxicity of azathioprine. Gastroenterol Clin Biol 1993; 17(11): 863–7

    PubMed  CAS  Google Scholar 

  5. Liano F, Moreno A, Matesanz R, et al. Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause? Nephron 1989; 51: 509–16

    Article  PubMed  CAS  Google Scholar 

  6. Horsmans Y, Rahier J, Geubel AR Reversible cholestasis with bile duct injury following azathioprine therapy. A case report. Liver 1991; 11: 89–93

    CAS  Google Scholar 

  7. Small P, Lichter M. Probable azathioprine hepatotoxicity: a case report. Ann Allergy 1989; 62; 518–20

    PubMed  CAS  Google Scholar 

  8. Mion F, Napoleon B, Berger F, et al. Azathioprine-induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis. Gut 1991 Jun; 32(6): 715–7

    Article  PubMed  CAS  Google Scholar 

  9. Pol S, Cavalcanti R, Carnot F, et al. Azathioprine hepatitis in kidney transplant recipients. A predisposing role of viral hepatitis. Transplantation 1996; 61: 1774–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hadassah-Hebrew University, Jerusalem, Israel

    M. Muszkat, O. Pappo, Y. Caraco &  Y. S. Haviv

  2. Department of Pathology and Nephrology, Hadassah-Hebrew University, Jerusalem, Israel

    M. Muszkat, O. Pappo, Y. Caraco &  Y. S. Haviv

Authors
  1. M. Muszkat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Pappo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Caraco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. S. Haviv
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muszkat, M., Pappo, O., Caraco, Y. et al. Hepatocanalicular Cholestasis after 24 Years of Azathioprine Administration for Myasthenia Gravis. Clin. Drug Investig. 19, 75–78 (2000). https://doi.org/10.2165/00044011-200019010-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200019010-00010

Keywords

Search

Navigation